20
Intas Pharmaceuticals Limited North Harrow Gb, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Docetaxel, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2012-301 - Rev 00
This Chemical Type CEP, issued on September 10, 2013, remains in force until June 27, 2018, ensuring its reliability within the pharmaceutical industry.
Substance Number 2593 associated with this CEP further emphasizes